Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30 SEK | -2.91% |
|
-15.49% | -42.31% |
May. 15 | Genovis AB (publ.) Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 14 | Carthesian Therapeutics Terminates Genovis AB (Publ.) Licence Agreement | CI |
Sales 2024 * | 154M 14.61M | Sales 2025 * | 189M 18.01M | Capitalization | 1.96B 187M |
---|---|---|---|---|---|
Net income 2024 * | 40M 3.81M | Net income 2025 * | 49M 4.66M | EV / Sales 2024 * | 12.1 x |
Net cash position 2024 * | 108M 10.3M | Net cash position 2025 * | 128M 12.17M | EV / Sales 2025 * | 9.7 x |
P/E ratio 2024 * |
48.5
x | P/E ratio 2025 * |
40.9
x | Employees | 36 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 0% |
1 day | -2.91% | ||
1 week | -15.49% | ||
Current month | -21.57% | ||
1 month | +2.92% | ||
3 months | -10.58% | ||
6 months | -41.75% | ||
Current year | -42.31% |
![Extreme 29.7](/images/extremecours_fleche.png)
![Extreme 29.7](/images/extremecours_fleche.png)
![Extreme 25.65](/images/extremecours_fleche.png)
![Extreme 25.65](/images/extremecours_fleche.png)
![Extreme 25.65](/images/extremecours_fleche.png)
![Extreme 15.65](/images/extremecours_fleche.png)
![Extreme 1.26](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Fredrik Olsson
CEO | Chief Executive Officer | 53 | 01-12-31 |
Magnus Långberg
DFI | Director of Finance/CFO | 53 | 21-12-31 |
Rolf Lood
CTO | Chief Tech/Sci/R&D Officer | 40 | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 72 | 20-05-04 | |
Director/Board Member | 63 | 18-12-31 | |
Mikael Lönn
BRD | Director/Board Member | 75 | 13-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-14 | 30 | -2.91% | 84,050 |
24-06-13 | 30.9 | -3.74% | 60,733 |
24-06-12 | 32.1 | +0.47% | 176,878 |
24-06-11 | 31.95 | -6.30% | 121,347 |
24-06-10 | 34.1 | -3.94% | 47,023 |
Delayed Quote Nasdaq Stockholm, June 14, 2024 at 12:00 pm EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.31% | 186M | |
-9.74% | 11.48B | |
-9.80% | 7.64B | |
+5.08% | 5.58B | |
+27.84% | 5.49B | |
-15.47% | 3.86B | |
+8.47% | 2.61B | |
-63.81% | 2.42B | |
-9.24% | 2.27B | |
+21.21% | 2.1B |
- Stock Market
- Equities
- GENO Stock